AlHilli M[au] - Search Results

Year	Number of Results
1983	1
2011	3
2012	5
2013	7
2014	4
2015	4
2016	1
2018	4
2019	4
2020	6
2021	7
2022	4
2023	2

1

Controversies in Hereditary Cancer Management.

AlHilli MM, Pederson HJ. AlHilli MM, et al. Obstet Gynecol. 2021 May 1;137(5):941-955. doi: 10.1097/AOG.0000000000004364. Obstet Gynecol. 2021. PMID: 33831930

2

International gynecologic cancer society (IGCS) 2021 meeting report.

AlHilli MM, Arend RC. AlHilli MM, et al. Gynecol Oncol. 2022 Jan;164(1):208-211. doi: 10.1016/j.ygyno.2021.10.086. Epub 2021 Nov 1. Gynecol Oncol. 2022. PMID: 34736783 No abstract available.

3

Diet and gut microbiome interactions in gynecologic cancer.

AlHilli MM, Bae-Jump V. AlHilli MM, et al. Gynecol Oncol. 2020 Nov;159(2):299-308. doi: 10.1016/j.ygyno.2020.08.027. Epub 2020 Sep 12. Gynecol Oncol. 2020. PMID: 32933758 Review.

4

Perioperative Management of Women Undergoing Risk-reducing Surgery for Hereditary Breast and Ovarian Cancer.

AlHilli MM, Al-Hilli Z. AlHilli MM, et al. J Minim Invasive Gynecol. 2019 Feb;26(2):253-265. doi: 10.1016/j.jmig.2018.09.767. Epub 2018 Sep 19. J Minim Invasive Gynecol. 2019. PMID: 30240898 Review.

5

The role of para-aortic lymphadenectomy in endometrial cancer.

AlHilli MM, Mariani A. AlHilli MM, et al. Int J Clin Oncol. 2013 Apr;18(2):193-9. doi: 10.1007/s10147-013-0528-7. Epub 2013 Feb 15. Int J Clin Oncol. 2013. PMID: 23412768 Review.

6

Preoperative selection of endometrial cancer patients at low risk for lymph node metastases: useful criteria for enrollment in clinical trials.

AlHilli MM, Mariani A. AlHilli MM, et al. J Gynecol Oncol. 2014 Oct;25(4):267-9. doi: 10.3802/jgo.2014.25.4.267. J Gynecol Oncol. 2014. PMID: 25310031 Free PMC article. No abstract available.

7

Endometrial cancer after endometrial ablation: systematic review of medical literature.

AlHilli MM, Hopkins MR, Famuyide AO. AlHilli MM, et al. J Minim Invasive Gynecol. 2011 May-Jun;18(3):393-400. doi: 10.1016/j.jmig.2011.02.004. J Minim Invasive Gynecol. 2011. PMID: 21545966 Review.

8

Aromatase inhibitors in the treatment of recurrent ovarian granulosa cell tumors: brief report and review of the literature.

Alhilli MM, Long HJ, Podratz KC, Bakkum-Gamez JN. Alhilli MM, et al. J Obstet Gynaecol Res. 2012 Jan;38(1):340-4. doi: 10.1111/j.1447-0756.2011.01698.x. Epub 2011 Dec 5. J Obstet Gynaecol Res. 2012. PMID: 22136798 Review.

9

Comprehensive Care of Women With Genetic Predisposition to Breast and Ovarian Cancer.

AlHilli MM, Batur P, Hurley K, Al-Hilli Z, Coombs D, Schwarz G, Djohan R, Marquard J, Ashton K, Pederson HJ. AlHilli MM, et al. Mayo Clin Proc. 2023 Mar 3:S0025-6196(23)00001-0. doi: 10.1016/j.mayocp.2023.01.001. Online ahead of print. Mayo Clin Proc. 2023. PMID: 36870859 Review.

10

Not all stage I and II endometrial cancers are created equal: Recurrence-free survival and cause-specific survival after observation or vaginal brachytherapy alone in all subgroups of early-stage high-intermediate and high-risk endometrial cancer.

Garzon S, Grassi T, Mariani A, Kollikonda S, Weaver AL, McGree ME, Petersen IA, Weroha SJ, Glaser GE, Langstraat CL, Amarnath SR, AlHilli MM. Garzon S, et al. Among authors: alhilli mm. Gynecol Oncol. 2022 Dec;167(3):444-451. doi: 10.1016/j.ygyno.2022.10.004. Epub 2022 Oct 14. Gynecol Oncol. 2022. PMID: 36244826

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results